Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
Use this AARD page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AARD quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AARD SEC filings page. Lician reads the product cache first so this HTML stays unique to Aardvark Therapeutics, Inc. Common Stock even when a live quote feed is slow.
Latest cached year on this hub. Full AARD income, balance, and cash tables.